USPTO serial 79281339
DNA UNIVERSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 2, 2021
- Examiner
- EUBANK, REBECCA A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with DNA UNIVERSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*
Plus Government fees of $1,950
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
EUROFINS SCIENTIFIC (IRELAND) LIMITED
IE
Other trademarks owned by EUROFINS SCIENTIFIC (IRELAND) LIMITED
EUROFINS SCIENTIFIC (IRELAND) LIMITED
IE
Other trademarks owned by EUROFINS SCIENTIFIC (IRELAND) LIMITED
EUROFINS SCIENTIFIC (IRELAND) LIMITED
IE
Other trademarks owned by EUROFINS SCIENTIFIC (IRELAND) LIMITED
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ronni S. Jillions
Ronni S. Jillions FisherBroyles, LLP1625 K St., NWSuite 550Washington, DC 20006Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents for non-medical purposes, diagnostic preparations and materials for scientific use, molecular tools, namely, reagents commonly known as probes and reaction primers in the nature of polymerase chain reaction primers and test portions in the nature of oligonucleotides for use in testing and analysis, all for scientific use; analytical and diagnostic test kits for research and scientific use comprised of reagents and buffers; chemical compounds used in research, scientific use and for non-medical purposes, in particular oligonucleotides, polynucleotides; peptide-chips of a chemical nature for industrial and/or scientific use; fragments, namely, chemical lead fragments and their combinations for scientific use and for non-medical purposes; nucleic acid sequences, chemical reagents for use with microarrays, peptide-microarrays and biochips, all for industrial use | ACTIVE | — |
| 005 | Diagnostic preparations for medical and veterinary purposes; chemical test reagents in the nature of diagnostic tests for disease testing, medical diagnostic tests for medical and veterinary purposes; biological reagents for drug testing and diagnostic purposes for medical use and veterinary use; medical and veterinary diagnostic reagents; chemical reagents for medical and veterinary use; oligonucleotides, namely, short molecules used in medical biochemical testing; polynucleotides, namely, chains of molecules used for medical biochemical testing; fragments, namely, chemical lead fragments and their combinations for medical use; all these products in relation with medical or veterinary purposes | ACTIVE | — |
| 009 | Computer programs, recorded, for DNA structure prediction and identification; computer programs in the nature of downloadable software for DNA structure prediction and identification | ACTIVE | — |
| 038 | Rental of access time for databases, computer networks and central computers; providing access to the internet enabling the user to interact with programs for data processing via the internet; providing access to the internet enabling the user to interact with programs for data processing via computer networks; providing access to the internet enabling the user to interact with non-downloadable computer software | ACTIVE | — |
| 042 | Research and development in the field of animal and plant biology, physical chemistry and microbiology; carrying out physical, chemical, physical chemical, biochemical, biological or microbiological analyses, namely, scientific analysis in the fields of zoology and botany ; carrying out physical, chemical, physical chemical, biochemical, biological or microbiological analyses, namely, scientific analysis in the field of food, chemicals, pharmaceuticals, cosmetics, and environmental protection; scientific analysis conducted by means of nuclear magnetic resonance in the field of food, chemicals, pharmaceuticals, cosmetics, and environmental protection; scientific and industrial research in the field of food, chemicals, pharmaceuticals; scientific research, namely, carrying out scientific research using chemical, biological or molecular biological methods and producing expert reports with findings related thereto for scientists and engineers for scientific, medical or industrial purposes; technical project studies in the nature of technical research in the field of DNA sequencing; professional consultancy in the field of scientific research and scientific research of DNA treatments for disease | ACTIVE | — |
| 044 | medical and veterinary services, namely, services for the testing of human or animal blood, sera, saliva, urine, feces and body fluids; medical consultation; rental of medical equipment; providing online medical record services, namely, providing online medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical diagnostic testing, monitoring and reporting in the field of cardiovascular disease; providing information relating to cardiovascular health and cardiovascular health testing; health care services, namely, health and wellness programs in the field of cardiovascular disease; medical testing for diagnostic and treatment purposes; medical diagnostic testing in the field of diabetes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EUROFINS SCIENTIFIC (IRELAND) LIMITED
- Other trademarks owned by EUROFINS SCIENTIFIC (IRELAND) LIMITED
- Other trademarks owned by EUROFINS SCIENTIFIC (IRELAND) LIMITED
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DNA UNIVERSE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 2, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 15, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 15, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 3, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 3, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 3, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 3, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 30, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 5, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 5, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 2, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 2, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 17, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 17, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 28, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 8, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 6, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 5, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 5, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 3, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 3, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 18, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 17, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2020 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Mar 27, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 26, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 25, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 23, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 23, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 19, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |